☰

Janet M. Pavese, Ph.D. - Publications

Affiliations: 
2014 Life Sciences Northwestern University, Evanston, IL 
Area:
Oncology
Tree Info Similar researchers PubMed Report error

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Xu L, Gordon R, Farmer R, Pattanayak A, Binkowski A, Huang X, Avram M, Krishna S, Voll E, Pavese J, Chavez J, Bruce J, Mazar A, Nibbs A, Anderson W, et al. Precision therapeutic targeting of human cancer cell motility. Nature Communications. 9: 2454. PMID 29934502 DOI: 10.1038/S41467-018-04465-5  0.728
2014 Pavese JM, Ogden IM, Voll EA, Huang X, Xu L, Jovanovic B, Bergan RC. Mitogen-activated protein kinase kinase 4 (MAP2K4) promotes human prostate cancer metastasis. Plos One. 9: e102289. PMID 25019290 DOI: 10.1371/Journal.Pone.0102289  0.784
2014 Pavese JM, Bergan RC. Circulating tumor cells exhibit a biologically aggressive cancer phenotype accompanied by selective resistance to chemotherapy. Cancer Letters. 352: 179-86. PMID 25016063 DOI: 10.1016/J.Canlet.2014.06.012  0.739
2014 Pavese JM, Krishna SN, Bergan RC. Genistein inhibits human prostate cancer cell detachment, invasion, and metastasis. The American Journal of Clinical Nutrition. 100: 431S-6S. PMID 24871471 DOI: 10.3945/Ajcn.113.071290  0.813
2014 Voll EA, Ogden IM, Pavese JM, Huang X, Xu L, Jovanovic BD, Bergan RC. Heat shock protein 27 regulates human prostate cancer cell motility and metastatic progression. Oncotarget. 5: 2648-63. PMID 24798191 DOI: 10.18632/Oncotarget.1917  0.783
2013 Pavese J, Ogden IM, Bergan RC. An orthotopic murine model of human prostate cancer metastasis. Journal of Visualized Experiments : Jove. e50873. PMID 24084571 DOI: 10.3791/50873  0.74
2012 Xu L, Farmer R, Huang X, Pruell S, Voll E, Pavese J, Valsecchi M, Biddle M, Nibbs A, Avram M, Scheidt KA, Bergan RC. Abstract 4752: Selective inhibition of cancer metastasis with a novel small therapeutic molecule Cancer Research. 72: 4752-4752. DOI: 10.1158/1538-7445.Am2012-4752  0.795
2012 Pavese JM, Ogden I, Huang X, Bergan R. Abstract 3277: Increased mitogen-activated protein kinase kinase 4 (MEK4) induces metastasis in an orthotopic murine model of prostate cancer Cancer Research. 72: 3277-3277. DOI: 10.1158/1538-7445.Am2012-3277  0.747
2011 Pavese JM, Ogden IM, Huang X, Xu L, Bergan RC. Abstract 1407: Mitogen-activated protein kinase kinase 4 (MEK4) is a key regulator of prostate cancer progression Cancer Research. 71: 1407-1407. DOI: 10.1158/1538-7445.Am2011-1407  0.777
2011 Xu L, Farmer R, Huang X, Valsecchi M, Pavese J, Voll E, Biddle M, Nibbs A, Pruell S, Avram M, Scheidt K, Bergan RC. Abstract C177: Chemical-driven biological probing: Discovery of a novel antimetastatic drug. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-C177  0.79
2010 Pavese JM, Farmer RL, Bergan RC. Inhibition of cancer cell invasion and metastasis by genistein. Cancer Metastasis Reviews. 29: 465-82. PMID 20730632 DOI: 10.1007/S10555-010-9238-Z  0.79
2010 Xu L, Farmer R, huang x, Pavese J, Voll E, Irene O, Biddle M, Nibbs A, Valsecchi M, Scheidt K, Bergan R. Abstract B58: Discovery of a novel drug KBU2046 that inhibits conversion of human prostate cancer to a metastatic phenotype Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-10-B58  0.804
Show low-probability matches.